Zkusit zdarma
ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc.

ALXO
Cena:
$ 1.98
-0.01 (-0.50%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?

Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?

10:41 12-05-2026

Here is how ALX Oncology Holdings Inc. (ALXO) and Biodesix, Inc. (BDSX) have performed compared to t...

ALX Oncology Holdings Inc. (ALXO) Q1 2026 Earnings Call Transcript

ALX Oncology Holdings Inc. (ALXO) Q1 2026 Earnings Call Transcript

4:01 09-05-2026

ALX Oncology Holdings Inc. (ALXO) Q1 2026 Earnings Call Transcript...

ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update

ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update

8:00 08-05-2026

- Data from Phase 1b/2 trial of evorpaceptzanidatamab presented at ESMO Breast Cancer 2026 showed al...

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Short Interest Update

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Short Interest Update

5:36 13-04-2026

ALX Oncology Holdings Inc. (NASDAQ: ALXO - Get Free Report) saw a significant growth in short intere...

Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?

Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?

10:40 09-02-2026

Here is how ALX Oncology Holdings Inc. (ALXO) and Amneal Pharmaceuticals (AMRX) have performed compa...

Corey Goodman Acquires 3,184,713 Shares of ALX Oncology (NASDAQ:ALXO) Stock

Corey Goodman Acquires 3,184,713 Shares of ALX Oncology (NASDAQ:ALXO) Stock

4:21 06-02-2026

ALX Oncology Holdings Inc. (NASDAQ: ALXO - Get Free Report) Director Corey Goodman acquired 3,184,71...

ALX Oncology Holdings Inc. (ALXO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

ALX Oncology Holdings Inc. (ALXO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

17:25 15-01-2026

ALX Oncology Holdings Inc. (ALXO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcri...

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Brokerages

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Brokerages

1:38 02-01-2026

ALX Oncology Holdings Inc. (NASDAQ: ALXO - Get Free Report) has been assigned an average rating of "...

Short Interest in ALX Oncology Holdings Inc. (NASDAQ:ALXO) Expands By 32.0%

Short Interest in ALX Oncology Holdings Inc. (NASDAQ:ALXO) Expands By 32.0%

5:14 30-12-2025

ALX Oncology Holdings Inc. (NASDAQ: ALXO - Get Free Report) was the recipient of a significant incre...

ALX Oncology Holdings Inc. (ALXO) Q3 2025 Earnings Call Transcript

ALX Oncology Holdings Inc. (ALXO) Q3 2025 Earnings Call Transcript

15:56 07-11-2025

ALX Oncology Holdings Inc. ( ALXO ) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Parti...

ALX Oncology (ALXO) Expected to Announce Earnings on Friday

ALX Oncology (ALXO) Expected to Announce Earnings on Friday

1:02 06-11-2025

ALX Oncology (NASDAQ: ALXO - Get Free Report) is expected to be posting its Q3 2025 results before t...

ALX Oncology Holdings Inc. (ALXO) Q2 2025 Earnings Call Transcript

ALX Oncology Holdings Inc. (ALXO) Q2 2025 Earnings Call Transcript

21:45 12-08-2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO ) Q2 2025 Earnings Conference Call August 12, 2023 4:30 AM E...

ALX Oncology Holdings (ALXO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

ALX Oncology Holdings (ALXO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

10:55 20-03-2025

ALX Oncology Holdings (ALXO) appears to have found support after losing some value lately, as indica...

Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?

Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?

10:41 07-01-2025

Here is how ALX Oncology Holdings Inc. (ALXO) and Ginkgo Bioworks Holdings, Inc. (DNA) have performe...

ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

10:35 21-11-2024

ALX Oncology Holdings (ALXO) is technically in oversold territory now, so the heavy selling pressure...

Down -30.79% in 4 Weeks, Here's Why ALX Oncology Holdings (ALXO) Looks Ripe for a Turnaround

Down -30.79% in 4 Weeks, Here's Why ALX Oncology Holdings (ALXO) Looks Ripe for a Turnaround

10:36 03-06-2024

The heavy selling pressure might have exhausted for ALX Oncology Holdings (ALXO) as it is technicall...

Wall Street Analysts Think ALX Oncology Holdings (ALXO) Could Surge 36.64%: Read This Before Placing a Bet

Wall Street Analysts Think ALX Oncology Holdings (ALXO) Could Surge 36.64%: Read This Before Placing a Bet

10:56 14-05-2024

The mean of analysts' price targets for ALX Oncology Holdings (ALXO) points to a 36.6% upside in the...

ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study

ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study

10:31 11-04-2024

ALX Oncology (ALXO) announces positive results from an early to mid-stage study of an investigationa...

7 Small-Cap Stocks That Wall Street Loves for Good Reason

7 Small-Cap Stocks That Wall Street Loves for Good Reason

16:21 22-12-2023

As we head into 2024, it's common for investors to look back on 2023. Much of this year had investor...

ALX Oncology: On Right Track With Latest Interim Analysis Of Evorpacept

ALX Oncology: On Right Track With Latest Interim Analysis Of Evorpacept

0:38 09-10-2023

ALX Oncology reported positive interim results from its phase 2 study using its anti-CD47 drug for H...

close

ALX ONCOLOGY ANNOUNCES PRICING OF UNDERWRITTEN OFFERING

30-01-2026
SOUTH SAN FRANCISCO, CALIF., JAN. 30, 2026 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC. (“ALX ON...
Více zde

NEW DATA DEMONSTRATE CD47 EXPRESSION LEVEL HELPS PREDICT RESPONSE TO ALX ONCOLOGY'S EVORPACEPT IN COMBINATION WITH ZIIHERA (ZANIDATAMAB-HRII) IN ADVANCED HER2-POSITIVE BREAST CANCER

30-01-2026
- EXPLORATORY ANALYSIS FROM PHASE 1B/2 BREAST CANCER TRIAL REINFORCES CD47 AS A PREDICTIVE BIOMARKER...
Více zde

ALX ONCOLOGY TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

08-01-2026
SOUTH SAN FRANCISCO, CALIF., JAN. 08, 2026 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC. ("ALX ONCO...
Více zde

ALX ONCOLOGY ADVANCES SEPARATE CLINICAL TRIALS EVALUATING INVESTIGATIONAL CD47-INHIBITOR EVORPACEPT AND NOVEL EGFR-TARGETED ANTIBODY-DRUG CONJUGATE ALX2004

08-01-2026
- FIRST PATIENT DOSED IN PHASE 2 ASPEN-09-BREAST TRIAL EVALUATING EVORPACEPT IN COMBINATION WITH TRA...
Více zde

ALX ONCOLOGY ANNOUNCES POSITIVE RESULTS FROM ONGOING INVESTIGATOR-SPONSORED PHASE 2 TRIAL EVALUATING EVORPACEPT IN COMBINATION WITH STANDARD-OF-CARE TREATMENT IN PATIENTS WITH INDOLENT B-CELL NON-HODGKIN LYMPHOMA, AT ASH ANNUAL MEETING

07-12-2025
- COMBINATION OF EVORPACEPT PLUS RITUXIMAB AND LENALIDOMIDE (R 2 ) GENERATED COMPLETE RESPONSES (CR)...
Více zde

ALX ONCOLOGY TO PRESENT AT UPCOMING INVESTOR CONFERENCES

18-11-2025
SOUTH SAN FRANCISCO, CALIF., NOV. 18, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., ("ALX ONC...
Více zde

ALX ONCOLOGY REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

07-11-2025
SOUTH SAN FRANCISCO, CALIF., NOV. 07, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., (“ALX O...
Více zde

ALX ONCOLOGY TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS AND PIPELINE PROGRESS INCLUDING EVORPACEPT CD47 BIOMARKER DATA TO BE PRESENTED AT UPCOMING SITC ANNUAL MEETING

30-10-2025
SOUTH SAN FRANCISCO, CALIF., OCT. 30, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., ("ALX ONC...
Více zde

ALX ONCOLOGY ANNOUNCES PRECLINICAL DATA AND PHASE 1 TRIAL-IN-PROGRESS PRESENTATIONS OF ALX2004, A NOVEL EGFR-TARGETED ADC, AT 2025 AACR-NCI-EORTC CONFERENCE

23-10-2025
-TWO POSTER PRESENTATIONS SHOWCASE BEST- AND FIRST-IN-CLASS POTENTIAL OF ALX2004, A NOVEL, ANTIBODY-...
Více zde

ALX ONCOLOGY TO PRESENT UPDATED DATA FROM PHASE 2 ASPEN-06 TRIAL, HIGHLIGHTING CD47 EXPRESSION AS A PREDICTIVE BIOMARKER IN HER2+ GASTRIC CANCER, AT 40TH SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) ANNUAL MEETING

03-10-2025
SOUTH SAN FRANCISCO, CALIF., OCT. 03, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., (“ALX O...
Více zde

ALX ONCOLOGY APPOINTS BOARD MEMBER BARBARA KLENCKE, M.D., AS INTERIM CHIEF MEDICAL OFFICER

12-09-2025
SOUTH SAN FRANCISCO, CALIF., SEPT. 12, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., (“ALX ...
Více zde

ALX ONCOLOGY TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN SEPTEMBER

29-08-2025
SOUTH SAN FRANCISCO, CALIF., AUG. 29, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., ("ALX ONC...
Více zde

ALX ONCOLOGY DOSES FIRST PATIENT IN PHASE 1 DOSE ESCALATION TRIAL EVALUATING ADC ALX2004 FOR THE TREATMENT OF EGFR-EXPRESSING SOLID TUMORS

19-08-2025
- A POTENTIAL BEST- AND FIRST-IN-CLASS ANTIBODY-DRUG CONJUGATE (ADC) FOR THE TREATMENT OF EGFR-EXPRE...
Více zde

ALX ONCOLOGY REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

12-08-2025
– DATA FROM ASPEN-06 TRIAL HIGHLIGHTS CD47 EXPRESSION AS A KEY PREDICTIVE BIOMARKER OF GREATER RES...
Více zde

ALX ONCOLOGY TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 12, 2025

05-08-2025
SOUTH SAN FRANCISCO, CALIF., AUG. 05, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., ("ALX ONC...
Více zde

ALX ONCOLOGY TO PRESENT AT THE JEFFERIES 2025 GLOBAL HEALTHCARE CONFERENCE

30-05-2025
SOUTH SAN FRANCISCO, CALIF., MAY 30, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., ("ALX ONCO...
Více zde

ALX ONCOLOGY HIGHLIGHTS DIFFERENTIATED DESIGN, PRECLINICAL DATA AND DEVELOPMENT PLANS FOR EGFR-TARGETED ADC, ALX2004, IN R&D WEBCAST EVENT

20-05-2025
- A POTENTIAL BEST- AND FIRST-IN-CLASS ANTIBODY-DRUG CONJUGATE (ADC) FOR THE TREATMENT OF EGFR-EXPRE...
Více zde

ALX ONCOLOGY TO HOST R&D WEBCAST EVENT HIGHLIGHTING ITS NOVEL EGFR TARGETING ANTIBODY-DRUG CONJUGATE, ALX2004, ON MAY 20, 2025

13-05-2025
SOUTH SAN FRANCISCO, CALIF., MAY 13, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., ("ALX ONCO...
Více zde

ALX ONCOLOGY REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

08-05-2025
FOLLOWING ANNOUNCEMENT OF PRIORITIZED DEVELOPMENT STRATEGY FOR EVORPACEPT IN COMBINATION WITH ANTI-C...
Více zde

ALX ONCOLOGY TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS ON MAY 8, 2025

02-05-2025
SOUTH SAN FRANCISCO, CALIF., MAY 02, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., (“ALX ON...
Více zde

ALX ONCOLOGY ANNOUNCES ENCOURAGING FINAL RESULTS FROM PHASE 1 TRIAL EVALUATING EVORPACEPT IN COMBINATION WITH STANDARD-OF-CARE TREATMENT IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA

25-04-2025
- DATA TO BE PRESENTED AT AACR 2025 ANNUAL MEETING SUGGEST THE COMBINATION OF ALX ONCOLOGY'S INVESTI...
Více zde

ALX ONCOLOGY REPORTS ASPEN-03 AND ASPEN-04 PHASE 2 TRIALS EVALUATING EVORPACEPT WITH A CHECKPOINT INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCERS DID NOT MEET PRIMARY ENDPOINTS

25-04-2025
SOUTH SAN FRANCISCO, APRIL 25, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., (“ALX ONCOLOGY...
Více zde

ALX ONCOLOGY REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

06-03-2025
– PRESENTED POSITIVE UPDATED DATA FROM ASPEN-06 PHASE 2 TRIAL DEMONSTRATING EVORPACEPT GENERATES S...
Více zde

ALX ONCOLOGY HIGHLIGHTS FOCUSED EVORPACEPT DEVELOPMENT PLAN, CLINICAL PROGRESS AND CORPORATE UPDATES AT R&D DAY WEBCAST EVENT

05-03-2025
EVENT TO INCLUDE UPDATES ON ONGOING EVORPACEPT CLINICAL DEVELOPMENT PROGRAM AND INTRODUCTION OF CLIN...
Více zde

ALX ONCOLOGY TO REPORT FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS ON MARCH 6, 2025

27-02-2025
SOUTH SAN FRANCISCO, CALIF., FEB. 27, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., (“ALX O...
Více zde

ALX ONCOLOGY TO HOST VIRTUAL R&D DAY ON MARCH 5, 2025

18-02-2025
SOUTH SAN FRANCISCO, CALIF., FEB. 18, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., (“ALX O...
Více zde

ALX ONCOLOGY PRESENTS POSITIVE UPDATED DATA FROM ASPEN-06 PHASE 2 TRIAL DEMONSTRATING EVORPACEPT GENERATES STRONG RESPONSE AND DURABLE CLINICAL BENEFIT IN PATIENTS WITH HER2-POSITIVE GASTRIC CANCER

23-01-2025
SOUTH SAN FRANCISCO, CALIF., JAN. 23, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., (“ALX O...
Více zde

ALX ONCOLOGY REPORTS INDUCEMENT GRANT AS PERMITTED BY THE NASDAQ LISTING RULES

22-01-2025
SOUTH SAN FRANCISCO, CALIF., JAN. 22, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS, INC. (“ALX ...
Více zde

ALX ONCOLOGY TO HOST VIRTUAL COMPANY EVENT HIGHLIGHTING UPDATED DATA FROM ASPEN-06 PHASE 2 TRIAL PRESENTED AT 2025 ASCO GI

21-01-2025
SOUTH SAN FRANCISCO, CALIF., JAN. 21, 2025 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC., (“ALX O...
Více zde

ALX ONCOLOGY TO PRESENT UPDATED RESULTS FROM PHASE 2 ASPEN-06 CLINICAL TRIAL OF EVORPACEPT IN PATIENTS WITH HER2-POSITIVE GASTRIC CANCER IN ORAL PRESENTATION AT 2025 ASCO GASTROINTESTINAL CANCERS SYMPOSIUM

18-12-2024
SOUTH SAN FRANCISCO, CALIF., DEC. 18, 2024 (GLOBE NEWSWIRE) -- ALX ONCOLOGY HOLDINGS INC. (“ALX ON...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-30 00:00:008-KStáhnout
2026-01-21 00:00:008-KStáhnout
2025-11-07 00:00:008-KStáhnout
2025-11-07 00:00:0010-QStáhnout
2025-09-12 01:00:008-KStáhnout
2025-09-12 00:00:008-KStáhnout
2025-08-12 01:00:008-KStáhnout
2025-08-12 01:00:0010-QStáhnout
2025-08-12 00:00:008-KStáhnout
2025-08-12 00:00:0010-QStáhnout
2025-06-12 01:00:008-KStáhnout
2025-06-12 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-04-25 01:00:008-KStáhnout
2025-04-25 00:00:008-KStáhnout
2025-03-06 00:00:008-KStáhnout
2025-03-06 00:00:0010-KStáhnout
2025-03-05 23:00:008-KStáhnout
2025-03-05 23:00:0010-KStáhnout
2025-03-05 00:00:008-KStáhnout
2025-03-04 23:00:008-KStáhnout
2025-01-22 00:00:008-KStáhnout
2025-01-21 23:00:008-KStáhnout
2025-01-17 00:00:008-KStáhnout
2025-01-16 23:00:008-KStáhnout
2024-11-14 00:00:008-KStáhnout
2024-11-13 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-10-04 01:00:008-KStáhnout
2024-10-04 00:00:008-KStáhnout
2024-08-12 01:00:0010-QStáhnout
2024-08-12 00:00:0010-QStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 00:00:008-KStáhnout
2024-06-17 01:00:008-KStáhnout
2024-06-17 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-05-02 01:00:008-KStáhnout
2024-05-02 00:00:008-KStáhnout
2024-03-07 00:00:008-KStáhnout
2024-03-07 00:00:0010-KStáhnout
2024-03-06 23:00:008-KStáhnout
2024-03-06 23:00:0010-KStáhnout
2023-12-26 00:00:008-KStáhnout
2023-12-25 23:00:008-KStáhnout
2023-11-13 00:00:008-KStáhnout
2023-11-13 00:00:0010-QStáhnout
2023-11-12 23:00:008-KStáhnout
2023-11-12 23:00:0010-QStáhnout
2023-10-06 01:00:008-KStáhnout
2023-10-06 00:00:008-KStáhnout
2023-10-04 01:00:008-KStáhnout
2023-10-04 00:00:008-KStáhnout
2023-09-06 01:00:008-KStáhnout
2023-09-06 00:00:008-KStáhnout
2023-08-10 01:00:008-KStáhnout
2023-08-10 01:00:0010-QStáhnout
2023-08-10 00:00:008-KStáhnout
2023-08-10 00:00:0010-QStáhnout
2023-06-20 01:00:008-KStáhnout
2023-06-20 00:00:008-KStáhnout
2023-05-11 01:00:008-KStáhnout
2023-05-11 01:00:0010-QStáhnout
2023-05-11 00:00:008-KStáhnout
2023-05-11 00:00:0010-QStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-12 23:00:008-KStáhnout
2023-03-09 00:00:008-KStáhnout
2023-03-09 00:00:0010-KStáhnout
2023-03-08 23:00:008-KStáhnout
2023-03-08 23:00:0010-KStáhnout
2022-11-29 00:00:008-KStáhnout
2022-11-28 23:00:008-KStáhnout
2022-11-08 00:00:008-KStáhnout
2022-11-08 00:00:0010-QStáhnout
2022-11-07 23:00:008-KStáhnout
2022-11-07 23:00:0010-QStáhnout
2022-10-31 00:00:008-KStáhnout
2022-10-30 23:00:008-KStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:008-KStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-06-16 01:00:008-KStáhnout
2022-06-16 00:00:008-KStáhnout
2022-05-09 01:00:008-KStáhnout
2022-05-09 01:00:0010-QStáhnout
2022-05-09 00:00:008-KStáhnout
2022-05-09 00:00:0010-QStáhnout
2022-04-12 01:00:008-KStáhnout
2022-04-12 00:00:008-KStáhnout
2022-02-28 00:00:008-KStáhnout
2022-02-28 00:00:0010-KStáhnout
2022-02-27 23:00:008-KStáhnout
2022-02-27 23:00:0010-KStáhnout
2021-12-17 00:00:008-KStáhnout
2021-12-16 23:00:008-KStáhnout
2021-11-12 00:00:008-KStáhnout
2021-11-12 00:00:0010-QStáhnout
2021-11-11 23:00:008-KStáhnout
2021-11-11 23:00:0010-QStáhnout
2021-10-07 01:00:008-KStáhnout
2021-10-07 00:00:008-KStáhnout
2021-08-27 01:00:008-KStáhnout
2021-08-27 00:00:008-KStáhnout
2021-08-12 01:00:008-KStáhnout
2021-08-12 01:00:0010-QStáhnout
2021-08-12 00:00:008-KStáhnout
2021-08-12 00:00:0010-QStáhnout
2021-06-15 01:00:008-KStáhnout
2021-06-15 00:00:008-KStáhnout
2021-05-17 01:00:008-KStáhnout
2021-05-17 01:00:0010-QStáhnout
2021-05-17 00:00:008-KStáhnout
2021-05-17 00:00:0010-QStáhnout
2021-05-04 01:00:008-KStáhnout
2021-05-04 00:00:008-KStáhnout
2021-03-25 00:00:008-KStáhnout
2021-03-24 23:00:008-KStáhnout
2021-03-18 00:00:008-KStáhnout
2021-03-18 00:00:0010-KStáhnout
2021-03-17 23:00:008-KStáhnout
2021-03-17 23:00:0010-KStáhnout
2021-03-15 00:00:008-KStáhnout
2021-03-14 23:00:008-KStáhnout
2020-12-23 00:00:008-KStáhnout
2020-12-22 23:00:008-KStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-12 00:00:0010-QStáhnout
2020-11-11 23:00:008-KStáhnout
2020-11-11 23:00:0010-QStáhnout
2020-08-27 01:00:008-KStáhnout
2020-08-27 01:00:0010-QStáhnout
2020-08-27 00:00:008-KStáhnout
2020-08-27 00:00:0010-QStáhnout
2020-07-21 01:00:008-KStáhnout
2020-07-21 00:00:008-KStáhnout
preloader